Glycemic State of Type 2 Diabetic Chronic Kidney Disease Patients after Vitamin D Replacement Therapy | ||||
| The Egyptian Journal of Hospital Medicine | ||||
| Article 5, Volume 76, Issue 6, July 2019, Page 4274-4278 PDF (263.22 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ejhm.2019.43807 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Haitham A.Azeem1; Ayman Abdel Aziz1; Alaa Mohammed Hashim2; Mohammed Ahmed1 | ||||
| 1Internal Medicine Department, Faculty of Medicine, Al-Azhar University | ||||
| 2Clinical Pathology Department, Faculty of Medicine, Al-Azhar University | ||||
| Abstract | ||||
| Background: Diabetes mellitus (DM) is a metabolic disorder characterized by chronic hyperglycaemia as a result of insulin deficiency, insulin resistance or both. Objective: To assess the impact of vitamin D replacement therapy on glycemic state in type 2 diabetic chronic kidney disease (CKD) patients. Patients and Methods: 70 patients previously diagnosed as type 2 DM (according to guidelines used by National Institute of Health USA) attending Al-Azhar Assuit University Hospital, internal medicine department and outpatient clinics was included in our study where vit. D was replaced in our groups and its impact on glycemic state was analyzed by bivariate and multivariate analyses. Results: Our study is a prospective study revealed a significant negative correlation between 25(OH)D levels and HbA1c values before and after vit. D replacement therapy. Conclusion: Vitamin D replacement therapy had a beneficial effect on glucose hemostasis via a significant reduction in HbA1c, this emphasizes the potential therapeutic implications of vitamin D supplementation as a promising preventative and therapeutic agent for improved glycemic control among type 2 DM patients with CKD | ||||
| Keywords | ||||
| HbA1c; Type 2 DM; Chronic Kidney Disease; Vit. D replacement; Intervention study | ||||
|
Statistics Article View: 204 PDF Download: 336 |
||||
